SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-240553
Filing Date
2023-09-22
Accepted
2023-09-22 16:37:30
Documents
15
Period of Report
2023-09-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d505692d8k.htm   iXBRL 8-K 32588
2 EX-3.1 d505692dex31.htm EX-3.1 8319
3 EX-99.1 d505692dex991.htm EX-99.1 11963
7 GRAPHIC g505692g0921202156155.jpg GRAPHIC 3024
  Complete submission text file 0001193125-23-240553.txt   192772

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20230922.xsd EX-101.SCH 2842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20230922_lab.xml EX-101.LAB 18724
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20230922_pre.xml EX-101.PRE 11699
9 EXTRACTED XBRL INSTANCE DOCUMENT d505692d8k_htm.xml XML 3597
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 231272177
SIC: 2834 Pharmaceutical Preparations